ADIPOQ and metabolic syndrome: These findings agree with other reports that show that ω-3 fatty acid (fish oil) supplementation decreases lipoprotein triacylglycerol secretion 59, modulates serum levels of adiponectin and leptin 45 and improves several features of metabolic syndrome associated with CVD 44,60-62.